- Report
- February 2026
- 276 Pages
Global
From €5117EUR$5,850USD£4,415GBP
- Report
- January 2026
- 198 Pages
Global
From €3445EUR$3,939USD£2,973GBP
- Report
- February 2026
- 422 Pages
Global
From €5117EUR$5,850USD£4,415GBP
- Report
- February 2026
- 186 Pages
Global
From €5117EUR$5,850USD£4,415GBP
- Report
- November 2024
- 96 Pages
Global
From €3500EUR$4,287USD£3,126GBP
- Report
- April 2024
- 104 Pages
Middle East, Africa
From €1312EUR$1,500USD£1,132GBP
- Report
- April 2024
- 104 Pages
Europe
From €1312EUR$1,500USD£1,132GBP

Urethral Meatal Stenosis (UMS) is a condition in which the urethral opening narrows, making it difficult to pass urine. It is most commonly seen in men, but can also occur in women. UMS is a common urological condition, and is often treated with a combination of medical and surgical interventions. Medical treatments include medications to relax the urethral muscles, and topical steroids to reduce inflammation. Surgical treatments include dilation of the urethral opening, and urethral reconstruction.
UMS can have a significant impact on quality of life, and can lead to urinary tract infections, incontinence, and other complications. Early diagnosis and treatment is important to prevent further complications.
Companies in the UMS market include Boston Scientific, Cook Medical, and Olympus. Show Less Read more